Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075313 Target Snapshot

Hemagglutinin · SINGLE PROTEIN · Influenza A virus (A/Puerto Rico/8/1934(H1N1))

26Compounds
30Assays
0Approved Drugs
21.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Hemagglutinin shows clinical signal disease relevance led by influenza. 1 more disease program remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P03452. Start with influenza, then reuse UniProt P03452 as the stable protein anchor across project notes and exports.

Review focus
Review-ready target frame

Start with influenza, then reuse UniProt P03452 as the stable protein anchor across project notes and exports.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14 1 linked drug
Open source guide
Disease program
influenza

Hemagglutinin shows clinical signal disease relevance led by influenza. 1 more disease program remain visible in the same review block. 1 linked drug remains visible in the same block.

Start review with influenza because it currently carries clinical signal support. Linked drugs include DIRIDAVUMAB. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Disease source · ChEMBL drug mechanism + indication proxy
Clinical signal Open Targets-ready proxy 1 linked drug
Open disease block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Hemagglutinin as ChEMBL target CHEMBL1075313, mapped to UniProt P03452. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Hemagglutinin
SINGLE PROTEIN · Influenza A virus (A/Puerto Rico/8/1934(H1N1))
As of 2026-09-14
ChEMBL target ID
CHEMBL1075313
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P03452
Hemagglutinin
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Hemagglutinin is the right protein anchor across sources, using UniProt P03452 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need to confirm why influenza is currently framed as clinical signal support. It currently carries 1 linked drug in the same disease frame.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHemagglutinin
UniProt AccessionP03452
Component TypeProtein
Sequence Length565 aa

Hemagglutinin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Hemagglutinin, mapped to UniProt P03452. Sequence length is 565 aa.

Mapped IDP03452
Review nameHemagglutinin
OrganismInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
Disease Relevance

Disease Relevance & Evidence Level

Open Targets-ready disease context using the current target-indication evidence contract.

Clinical signal Open Targets-ready proxy

Hemagglutinin shows clinical signal disease relevance led by influenza. 1 more disease program remain visible in the same review block.

Clinical signal Phase II
influenza
1 linked drug · 1 direct · 1 efficacy
Linked drugDIRIDAVUMAB
Clinical signal Phase II
swine influenza
1 linked drug · 1 direct · 1 efficacy
Linked drugDIRIDAVUMAB
Source · ChEMBL drug mechanism + indication proxy
Review Cue

How to read disease relevance

Start review with influenza because it currently carries clinical signal support. Linked drugs include DIRIDAVUMAB. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Lead diseaseinfluenza
Strongest levelClinical signal
Block modeOpen Targets-ready proxy
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC504.0
KD17.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1084188 8.11 Kd 7.8 Preclinical
CHEMBL1084191 8.11 Kd 7.8 Preclinical
CHEMBL1084190 7.96 Kd 11.0 Preclinical
CHEMBL1084192 7.72 Kd 19.0 Preclinical
CHEMBL1084189 7.52 Kd 30.0 Preclinical
CHEMBL4855404 5.58 Kd 2630.0 Preclinical
CHEMBL4645411 5.35 Kd 4500.0 Preclinical
CHEMBL4639026 5.2 Kd 6300.0 Preclinical
CHEMBL5632136 5.19 Kd 6400.0 Preclinical
CHEMBL1934618 5.11 IC50 7810.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
1
5.5
0
6.0
0
6.5
0
7.0
3
7.5
2
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

30
Total Assays
16
Tested Compounds
1
Assay Types
Binding — 30 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 13 3 5.0
assay format 9 0
single protein format 8 13 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine